This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shaw, L. N. Articles by Potempa, J. Search for Related Content PubMed PubMed Citation Articles by Shaw, L. N. Articles by Potempa, J.

Cytoplasmic Control of Premature Activation of a Secreted Protease Zymogen: Deletion of Staphostatin B (SspC) in Staphylococcus aureus 8325-4 Yields a Profound Pleiotropic Phenotype

Lindsey N. Shaw,^1, Ewa Golonka,^2, Grzegorz Szmyd,² Simon J. Foster,³ James Travis,¹ and Jan Potempa^1,2*

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia,¹ Faculty of Biotechnology, Jagiellonian University, Cracow, Poland,² Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, England³

Received 4 October 2004/ Accepted 29 November 2004

The cytoplasmic protein SspC of Staphylococcus aureus, referred to as staphostatin B, is a very specific, tightly binding inhibitor of the secreted protease staphopain B (SspB). SspC is hypothesized to protect intracellular proteins against proteolytic damage by prematurely folded and activated staphopain B (M. Rzychon, A. Sabat, K. Kosowska, J. Potempa, and A. Dubin, Mol. Microbiol. 49:1051-1066, 2003). Here we provide evidence that elimination of intracellular staphopain B activity is indeed the function of SspC. An isogenic sspC mutant of S. aureus 8325-4 exhibits a wide range of striking pleiotropic alterations in phenotype, which distinguish it from the parent. These changes include a defect in growth, a less structured peptidoglycan layer within the cell envelope, severely decreased autolytic activity, resistance to lysis by S. aureus phages, extensively diminished sensitivity to lysis by lysostaphin, the ability to form a biofilm, and a total lack of extracellular proteins secreted into the growth media. The same phenotype was also engineered by introduction of sspB into an 8325-4 sspBC mutant. In contrast, sspC inactivation in the SH1000 strain did not yield any significant changes in the mutant phenotype, apparently due to strongly reduced expression of sspB in the sigma B-positive background. The exact pathway by which these diverse aberrations are exerted in 8325-4 is unknown, but it is apparent that a very small amount of staphopain B (less than 20 ng per 200 µg of cell proteins) is sufficient to bring about these widespread changes. It is proposed that the effects observed are modulated through the proteolytic degradation of several cytoplasmic proteins within cells lacking the inhibitor. Seemingly, some of these proteins may play a role in protein secretion; hence, their proteolytic inactivation by SspB has pleiotropic effects on the SspC-deficient mutant.

L.N.S. and E.G. contributed equally to this work.

This article has been cited by other articles:

• Nickerson, N. N., Prasad, L., Jacob, L., Delbaere, L. T., McGavin, M. J. (2007). Activation of the SspA Serine Protease Zymogen of Staphylococcus aureus Proceeds through Unique Variations of a Trypsinogen-like Mechanism and Is Dependent on Both Autocatalytic and Metalloprotease-specific Processing. J. Biol. Chem. 282: 34129-34138 [Abstract] [Full Text]  
• Shaw, L. N., Jonsson, I.-M., Singh, V. K., Tarkowski, A., Stewart, G. C. (2007). Inactivation of traP Has No Effect on the Agr Quorum-Sensing System or Virulence of Staphylococcus aureus. Infect. Immun. 75: 4519-4527 [Abstract] [Full Text]  
• Shaw, L. N., Aish, J., Davenport, J. E., Brown, M. C., Lithgow, J. K., Simmonite, K., Crossley, H., Travis, J., Potempa, J., Foster, S. J. (2006). Investigations into {sigma}B-Modulated Regulatory Pathways Governing Extracellular Virulence Determinant Production in Staphylococcus aureus.. J. Bacteriol. 188: 6070-6080 [Abstract] [Full Text]  
• Wootton, M., Bennett, P. M., MacGowan, A. P., Walsh, T. R. (2005). Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J Antimicrob Chemother 56: 944-947 [Abstract] [Full Text]